Mesa Laboratories Stock Price, News & Analysis (NASDAQ:MLAB)

$130.04 1.84 (1.44 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$128.20
Today's Range$127.90 - $130.70
52-Week Range$113.57 - $169.80
Volume16,149 shs
Average Volume15,808 shs
Market Capitalization$478.52 million
P/E Ratio33.49
Dividend Yield0.51%
Beta0.41

About Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories logoMesa Laboratories, Inc. is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products. Its Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes. Its Continuous Monitoring Division designs, develops and markets systems, which are used to monitor various environmental parameters. Its Cold Chain Division provides parameter (primarily temperature) monitoring of products in a cold chain. The Company's brands include DataTrace, DialyGuard, DryCal, Torqo, SureTorque, BGI, Mesa, PCD, Apex, CheckPoint, Mesa and TempTrust.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Testing & Measuring Equipment
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Debt-to-Equity Ratio0.48%
Current Ratio2.86%
Quick Ratio1.97%

Price-To-Earnings

Trailing P/E Ratio33.49
Forward P/E Ratio52.65
P/E GrowthN/A

Sales & Book Value

Annual Sales$93.67 million
Price / Sales5.25
Cash Flow$6.93 per share
Price / Cash18.77
Book Value$26.43 per share
Price / Book4.92

Profitability

Trailing EPS$2.77
Net Income$11.18 million
Net Margins11.48%
Return on Equity14.77%
Return on Assets8.57%

Miscellaneous

Employees381
Outstanding Shares3,780,000

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, October 3rd. Stockholders of record on Thursday, November 30th will be given a dividend of $0.16 per share on Friday, December 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.49%. The ex-dividend date of this dividend is Wednesday, November 29th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings results on Monday, November, 6th. The medical instruments supplier reported $0.60 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.64 by $0.04. The medical instruments supplier earned $22.95 million during the quarter, compared to analysts' expectations of $25.50 million. Mesa Laboratories had a net margin of 11.48% and a return on equity of 14.77%. View Mesa Laboratories' Earnings History.

When will Mesa Laboratories make its next earnings announcement?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January, 31st 2018. View Earnings Estimates for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:

  • John J. Sullivan Ph.D., Chairman of the Board (Age 73)
  • Gary M. Owens, President, Chief Executive Officer, Chief Operating Officer, Director (Age 49)
  • John V. Sakys, Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary (Age 49)
  • Glenn E. Adriance, Chief Sales and Marketing Officer (Age 61)
  • H. Stuart Campbell, Lead Independent Director (Age 86)
  • Robert V. Dwyer, Director (Age 75)
  • John Bradley Schmieder, Director (Age 47)
  • Michael T. Brooks, Independent Director (Age 66)
  • Evan C. Guillemin, Independent Director (Age 50)

Who owns Mesa Laboratories stock?

Mesa Laboratories' stock is owned by many different of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (9.91%), Victory Capital Management Inc. (3.92%), Dimensional Fund Advisors LP (3.40%), Nine Ten Capital Management LLC (3.22%), Thomson Horstmann & Bryant Inc. (2.05%) and Royce & Associates LP (2.02%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.

Who sold Mesa Laboratories stock? Who is selling Mesa Laboratories stock?

Mesa Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Nine Ten Capital Management LLC, Kistler Tiffany Companies LLC, Bessemer Group Inc., Royce & Associates LP, Pembroke Management LTD, Dimensional Fund Advisors LP, Sapphire Star Partners LP and California State Teachers Retirement System. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Glenn E Adriance, H Stuart Campbell, John James Sullivan, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Who bought Mesa Laboratories stock? Who is buying Mesa Laboratories stock?

Mesa Laboratories' stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Victory Capital Management Inc., Raymond James Financial Services Advisors Inc., Schwab Charles Investment Management Inc., Susquehanna International Group LLP, Kayne Anderson Rudnick Investment Management LLC, Candriam Luxembourg S.C.A. and Thomson Horstmann & Bryant Inc.. View Insider Buying and Selling for Mesa Laboratories.

How do I buy Mesa Laboratories stock?

Shares of Mesa Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of Mesa Laboratories stock can currently be purchased for approximately $130.04.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $478.52 million and generates $93.67 million in revenue each year. The medical instruments supplier earns $11.18 million in net income (profit) each year or $2.77 on an earnings per share basis. Mesa Laboratories employs 381 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (MLAB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mesa Laboratories (NASDAQ:MLAB) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$132.00$132.00$119.00
Price Target Upside: N/A3.21% upside3.21% upside6.96% downside

Mesa Laboratories (NASDAQ:MLAB) Consensus Price Target History

Price Target History for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
6/10/2016SidotiDowngradeBuy -> Neutral$132.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Mesa Laboratories (NASDAQ:MLAB) Earnings History and Estimates Chart

Earnings by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2018N/AView Earnings Details
11/6/2017Q2 2018$0.64$0.60$25.50 million$22.95 millionViewN/AView Earnings Details
7/31/2017Q1 2018$0.56$0.39$22.90 million$22.67 millionViewN/AView Earnings Details
6/7/2017Q4 2017$1.00$1.24$27.10 million$24.30 millionViewN/AView Earnings Details
2/2/2017Q3 2017$0.62$1.19$22.60 million$23.84 millionViewN/AView Earnings Details
11/2/2016Q217$0.85$0.92$23.80 million$24.40 millionViewN/AView Earnings Details
7/28/2016Q1$0.89$0.89$21.20 million$21.11 millionViewN/AView Earnings Details
6/2/2016Q4$0.94$1.33$21.00 million$24.81 millionViewN/AView Earnings Details
8/3/2015Q116$0.83$0.85$18.78 billion$18.20 billionViewN/AView Earnings Details
6/1/2015Q415$0.91$0.80$18.56 millionViewN/AView Earnings Details
2/2/2015Q315$0.73$0.87$17.83 millionViewN/AView Earnings Details
11/3/2014Q215$0.69$0.84$12.68 million$18.54 millionViewN/AView Earnings Details
8/6/2014Q115$0.67$0.71$11.22 million$16.40 millionViewN/AView Earnings Details
6/2/2014Q414$0.70$1.15$12.80 million$15.70 millionViewN/AView Earnings Details
2/3/2014Q4$0.62ViewN/AView Earnings Details
5/29/2013Q113$0.59$0.76$13.13 million$12.81 millionViewN/AView Earnings Details
2/5/2013Q3 2013$0.67$0.56$11.76 million$11.36 millionViewN/AView Earnings Details
11/8/2012Q312$0.61$0.76$11.48 million$11.71 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Mesa Laboratories (NASDAQ:MLAB) Earnings Estimates

Current Year EPS Consensus Estimate: $2.47 EPS
Next Year EPS Consensus Estimate: $2.46 EPS

Dividends

Mesa Laboratories (NASDAQ:MLAB) Dividend Information

Next Dividend:12/15/2017
Annual Dividend:$0.64
Dividend Yield:0.49%
Dividend Growth:3.90% (3 Year Average)
Payout Ratio:23.10% (Trailing 12 Months of Earnings)
25.91% (Based on This Year's Estimates)
26.02% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/3/2017quarterly$0.160.42%11/29/201711/30/201712/15/2017
7/6/2017quarterly$0.160.45%8/29/20178/31/20179/15/2017
4/6/2017quarterly$0.160.5%5/26/20175/31/20176/15/2017
1/4/2017quarterly$0.160.51%2/24/20172/28/20173/15/2017
10/5/2016quarterly$0.160.54%11/28/201611/30/201612/15/2016
7/7/2016quarterly$0.160.52%8/29/20168/31/20169/15/2016
4/13/2016quarterly$0.160.64%5/26/20165/31/20166/15/2016
1/6/2016quarterly$0.160.71%2/25/20162/29/20163/15/2016
10/5/2015quarterly$0.160.57%11/25/201511/30/201512/15/2015
7/9/2015quarterly$0.160.72%8/27/20158/31/20159/15/2015
4/3/2015quarterly$0.160.93%5/27/20155/29/20156/15/2015
1/7/2015quarterly$0.160.84%2/25/20152/27/20153/16/2015
10/14/2014quarterly$0.160.95%11/25/201411/28/201412/15/2014
7/17/2014quarterly$0.150.73%8/27/20148/29/20149/15/2014
4/23/2014quarterly$0.150.69%5/28/20145/30/20146/16/2014
1/31/2014quarterly$0.150.75%2/26/20142/28/20143/17/2014
11/1/2013quarterly$0.150.88%11/26/201311/29/201312/16/2013
8/7/2013quarterly$0.140.92%8/28/20138/30/20139/18/2013
4/18/2013quarterly$0.141.1%5/22/20135/27/20136/24/2013
4/17/2013quarterly$0.145/27/20136/14/2013
2/6/2013quarterly$0.141.08%2/25/20132/27/20133/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Mesa Laboratories (NASDAQ MLAB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.70%
Institutional Ownership Percentage: 69.79%
Insider Trades by Quarter for Mesa Laboratories (NASDAQ:MLAB)
Insider Trades by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2017H Stuart CampbellDirectorSell1,000$130.16$130,160.00View SEC Filing  
8/18/2017H Stuart CampbellDirectorSell2,000$130.42$260,840.00View SEC Filing  
8/15/2017H Stuart CampbellDirectorSell2$134.10$268.20View SEC Filing  
8/11/2017H Stuart CampbellDirectorSell608$134.08$81,520.64View SEC Filing  
8/10/2017H Stuart CampbellDirectorSell1,000$136.58$136,580.00View SEC Filing  
8/9/2017H Stuart CampbellDirectorSell1,000$137.61$137,610.00View SEC Filing  
8/4/2017H Stuart CampbellDirectorSell1,000$143.09$143,090.00View SEC Filing  
8/3/2017H Stuart CampbellDirectorSell2,000$143.37$286,740.00View SEC Filing  
6/16/2017Robert V DwyerDirectorSell11,150$139.46$1,554,979.00View SEC Filing  
6/12/2017David M KellyDirectorSell1,000$142.00$142,000.00View SEC Filing  
6/9/2017Glenn E AdrianceInsiderSell4,000$148.98$595,920.00View SEC Filing  
3/20/2017Michael T BrooksDirectorSell2,000$122.94$245,880.00View SEC Filing  
2/22/2017Robert V DwyerDirectorSell5,000$125.13$625,650.00View SEC Filing  
2/21/2017John James SullivanInsiderSell9,078$124.83$1,133,206.74View SEC Filing  
2/13/2017John James SullivanCEOSell5,922$123.99$734,268.78View SEC Filing  
2/7/2017Glenn E AdrianceInsiderSell8,070$124.15$1,001,890.50View SEC Filing  
2/7/2017H Stuart CampbellDirectorSell8,000$121.55$972,400.00View SEC Filing  
11/23/2016Glenn E AdrianceInsiderSell3,567$135.93$484,862.31View SEC Filing  
11/17/2016John SakysCFOSell1,000$127.14$127,140.00View SEC Filing  
10/21/2016H Stuart CampbellDirectorSell4,000$119.02$476,080.00View SEC Filing  
9/16/2016H Stuart CampbellDirectorSell3,000$115.03$345,090.00View SEC Filing  
6/22/2016John James SullivanCEOSell4,000$121.63$486,520.00View SEC Filing  
6/6/2016Glenn E AdrianceInsiderSell3,000$111.74$335,220.00View SEC Filing  
3/11/2016H Stuart CampbellDirectorSell6,000$86.32$517,920.00View SEC Filing  
3/7/2016H Stuart CampbellDirectorSell280$90.00$25,200.00View SEC Filing  
2/24/2016H Stuart CampbellDirectorSell1,532$92.90$142,322.80View SEC Filing  
11/6/2015John James SullivanCEOSell2,400$112.99$271,176.00View SEC Filing  
9/22/2015H Stuart CampbellDirectorBuy150$109.54$16,431.00View SEC Filing  
9/17/2015Robert V DwyerDirectorSell2,000$113.00$226,000.00View SEC Filing  
9/15/2015Robert V DwyerDirectorSell3,000$111.67$335,010.00View SEC Filing  
9/11/2015Robert V DwyerDirectorSell1,000$110.00$110,000.00View SEC Filing  
9/8/2015Robert V DwyerDirectorSell1,000$110.39$110,390.00View SEC Filing  
8/17/2015Robert V DwyerDirectorSell1,937$116.50$225,660.50View SEC Filing  
3/14/2014Luke R SchmiederDirectorSell5,000$90.04$450,200.00View SEC Filing  
2/27/2014Glenn E AdrianceInsiderSell1,000$87.68$87,680.00View SEC Filing  
2/25/2014John James SullivanCEOSell10,000$87.01$870,100.00View SEC Filing  
12/9/2013Glenn E AdrianceInsiderSell4,825$73.68$355,506.00View SEC Filing  
11/15/2013Robert V DwyerDirectorSell13,476$71.33$961,243.08View SEC Filing  
11/14/2013Robert V DwyerDirectorSell6,524$71.33$465,356.92View SEC Filing  
8/19/2013John James SullivanCEOSell6,000$64.87$389,220.00View SEC Filing  
8/14/2013John James SullivanCEOSell6,000$61.92$371,520.00View SEC Filing  
3/5/2013H Stuart CampbellDirectorSell30,000$52.75$1,582,500.00View SEC Filing  
12/27/2012Steven W PetersonCFOSell17,054$48.50$827,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Mesa Laboratories (NASDAQ MLAB) News Headlines

Source:
DateHeadline
MKS Instruments (MKSI) and Mesa Laboratories (MLAB) Critical ContrastMKS Instruments (MKSI) and Mesa Laboratories (MLAB) Critical Contrast
www.americanbankingnews.com - December 12 at 9:34 PM
 Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - December 11 at 9:50 PM
Analysts Expect Mesa Laboratories, Inc. (MLAB) to Post $0.61 EPSAnalysts Expect Mesa Laboratories, Inc. (MLAB) to Post $0.61 EPS
www.americanbankingnews.com - December 8 at 11:52 PM
Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2017 (record date) : By the numbers : November 30, 2017Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2017 (record date) : By the numbers : November 30, 2017
finance.yahoo.com - November 30 at 5:30 PM
 Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Price Target by Brokerages Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Price Target by Brokerages
www.americanbankingnews.com - November 23 at 1:52 AM
 Mesa Laboratories, Inc. (MLAB) Given Consensus Rating of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 19 at 9:26 PM
Mesa Labs Acquires Sterilization and Disinfection Process Control BusinessMesa Labs Acquires Sterilization and Disinfection Process Control Business
finance.yahoo.com - November 9 at 5:37 AM
Mesa Laboratories, Inc. (MLAB) Releases Quarterly  Earnings Results, Misses Estimates By $0.04 EPSMesa Laboratories, Inc. (MLAB) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - November 7 at 12:34 PM
Colorado instrument company reports its reducing headcountColorado instrument company reports it's 'reducing headcount'
www.bizjournals.com - November 7 at 6:55 AM
Mesa Labs Reports Second Quarter ResultsMesa Labs Reports Second Quarter Results
www.thestreet.com - November 7 at 6:55 AM
Mid-Day Market Update: Mesa Laboratories Drops After Q2 Results; TherapeuticsMD Shares JumpMid-Day Market Update: Mesa Laboratories Drops After Q2 Results; TherapeuticsMD Shares Jump
feeds.benzinga.com - November 6 at 12:54 PM
Zacks: Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by AnalystsZacks: Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 4 at 7:40 PM
ETFs with exposure to Mesa Laboratories, Inc. : November 1, 2017ETFs with exposure to Mesa Laboratories, Inc. : November 1, 2017
finance.yahoo.com - November 2 at 6:28 AM
 Analysts Set $190.00 Price Target for Mesa Laboratories, Inc. (MLAB) Analysts Set $190.00 Price Target for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - October 28 at 7:50 PM
Mesa Laboratories (MLAB) and Vishay Precision Group (VPG) Head to Head AnalysisMesa Laboratories (MLAB) and Vishay Precision Group (VPG) Head to Head Analysis
www.americanbankingnews.com - October 19 at 4:10 PM
Zacks: Analysts Set $190.00 Target Price for Mesa Laboratories, Inc. (MLAB)Zacks: Analysts Set $190.00 Target Price for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - October 18 at 6:40 PM
Comparing Mesa Laboratories (MLAB) & BTU International (BTUI)Comparing Mesa Laboratories (MLAB) & BTU International (BTUI)
www.americanbankingnews.com - October 16 at 12:32 PM
Comparing Mesa Laboratories (MLAB) and The CompetitionComparing Mesa Laboratories (MLAB) and The Competition
www.americanbankingnews.com - October 14 at 8:22 PM
Head to Head Survey: Mesa Laboratories (MLAB) vs. Its CompetitorsHead to Head Survey: Mesa Laboratories (MLAB) vs. Its Competitors
www.americanbankingnews.com - October 14 at 2:18 AM
BRIEF-Mlabs Systems says entered into collaboration agreement with Malaysian University Of Science and TechnologyBRIEF-Mlabs Systems says entered into collaboration agreement with Malaysian University Of Science and Technology
finance.yahoo.com - October 13 at 6:54 AM
Brokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $0.55 EPSBrokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $0.55 EPS
www.americanbankingnews.com - October 11 at 2:20 PM
Analysts Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.55 Earnings Per ShareAnalysts Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.55 Earnings Per Share
www.americanbankingnews.com - October 7 at 12:36 PM
ETFs with exposure to Mesa Laboratories, Inc. : October 5, 2017ETFs with exposure to Mesa Laboratories, Inc. : October 5, 2017
finance.yahoo.com - October 7 at 6:03 AM
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health SolutionsThe Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
finance.yahoo.com - October 6 at 10:38 AM
Mesa Laboratories (MLAB) vs. The Competition Financial ReviewMesa Laboratories (MLAB) vs. The Competition Financial Review
www.americanbankingnews.com - October 5 at 10:20 PM
Mesa Labs Acquires Sterilization Process Control BusinessMesa Labs Acquires Sterilization Process Control Business
feeds.benzinga.com - October 5 at 4:22 PM
Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16
www.americanbankingnews.com - October 3 at 6:04 PM
Head-To-Head Review: BTU International (BTUI) versus Mesa Laboratories (MLAB)Head-To-Head Review: BTU International (BTUI) versus Mesa Laboratories (MLAB)
www.americanbankingnews.com - October 3 at 12:50 PM
Contrasting Mesa Laboratories (MLAB) & Its RivalsContrasting Mesa Laboratories (MLAB) & Its Rivals
www.americanbankingnews.com - September 30 at 6:26 AM
Mesa Laboratories (MLAB) and Its Competitors Critical ReviewMesa Laboratories (MLAB) and Its Competitors Critical Review
www.americanbankingnews.com - September 25 at 2:18 PM
Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : August 31st, 2017 (record date) : By the numbers : September 22, 2017Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : August 31st, 2017 (record date) : By the numbers : September 22, 2017
finance.yahoo.com - September 23 at 8:14 AM
Analyzing Chart Industries (GTLS) and Mesa Laboratories (MLAB)Analyzing Chart Industries (GTLS) and Mesa Laboratories (MLAB)
www.americanbankingnews.com - September 22 at 2:34 PM
ETFs with exposure to Mesa Laboratories, Inc. : September 19, 2017ETFs with exposure to Mesa Laboratories, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 6:21 AM
Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 10:49 PM
Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : MLAB-US : September 14, 2017Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : MLAB-US : September 14, 2017
finance.yahoo.com - September 14 at 4:04 PM
Lakewood instrument company names new CEOLakewood instrument company names new CEO
www.bizjournals.com - September 2 at 6:17 AM
Mesa Labs Reports Transition of its Chief Executive OfficerMesa Labs Reports Transition of its Chief Executive Officer
www.nasdaq.com - September 2 at 6:17 AM
Mesa Laboratories, Inc. (MLAB) Director H Stuart Campbell Sells 1,000 SharesMesa Laboratories, Inc. (MLAB) Director H Stuart Campbell Sells 1,000 Shares
www.americanbankingnews.com - August 22 at 7:34 PM
Mesa Laboratories, Inc. (MLAB) Director Sells $260,840.00 in StockMesa Laboratories, Inc. (MLAB) Director Sells $260,840.00 in Stock
www.americanbankingnews.com - August 21 at 1:28 PM
H Stuart Campbell Sells 608 Shares of Mesa Laboratories, Inc. (MLAB) StockH Stuart Campbell Sells 608 Shares of Mesa Laboratories, Inc. (MLAB) Stock
www.americanbankingnews.com - August 15 at 1:40 PM
 Mesa Laboratories, Inc. (NASDAQ:MLAB) Receives Consensus Recommendation of "Strong Buy" from Analysts Mesa Laboratories, Inc. (NASDAQ:MLAB) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - August 14 at 10:08 PM
Critical Analysis: Mesa Laboratories (MLAB) vs. ESCO Technologies (ESE)Critical Analysis: Mesa Laboratories (MLAB) vs. ESCO Technologies (ESE)
www.americanbankingnews.com - August 13 at 4:16 AM
Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 1,000 Shares of StockInsider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - August 11 at 1:18 PM
Mesa Laboratories, Inc. – Value Analysis (NASDAQ:MLAB) : August 7, 2017Mesa Laboratories, Inc. – Value Analysis (NASDAQ:MLAB) : August 7, 2017
finance.yahoo.com - August 7 at 8:02 PM
Mesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell Sells 2,000 SharesMesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell Sells 2,000 Shares
www.americanbankingnews.com - August 4 at 1:24 PM
Mesa Laboratories, Inc. (NASDAQ:MLAB) Releases  Earnings Results, Misses Expectations By $0.17 EPSMesa Laboratories, Inc. (NASDAQ:MLAB) Releases Earnings Results, Misses Expectations By $0.17 EPS
www.americanbankingnews.com - August 1 at 11:56 AM
Badger Meter (BMI) versus Mesa Laboratories (MLAB) Head to Head AnalysisBadger Meter (BMI) versus Mesa Laboratories (MLAB) Head to Head Analysis
www.americanbankingnews.com - July 31 at 10:24 PM
Mesa Labs Reports Record First Quarter RevenuesMesa Labs Reports Record First Quarter Revenues
www.nasdaq.com - July 31 at 8:17 PM
Mesa Labs posts 1Q profitMesa Labs posts 1Q profit
finance.yahoo.com - July 31 at 8:17 PM
Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : July 26, 2017Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : July 26, 2017
finance.yahoo.com - July 28 at 4:16 PM

SEC Filings

Mesa Laboratories (NASDAQ:MLAB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Mesa Laboratories (NASDAQ:MLAB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Mesa Laboratories (NASDAQ MLAB) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.